Financial Results (Standalone)

Quarterly Performance (₹ in Lakhs)

  • Revenue from Operations: Q1 FY27: ₹489.67; Q4 FY26: ₹536.74; Q1 FY26: ₹534.30
  • Other Income: Q1 FY27: ₹2.51; Q4 FY26: ₹4.44; Q1 FY26: ₹2.19
  • Total Revenue: Q1 FY27: ₹492.18; Q4 FY26: ₹541.18; Q1 FY26: ₹536.49

Expenses Breakdown (₹ in Lakhs)

  • Cost of materials consumed: ₹163.61 (Q1 FY27) vs ₹119.07 (Q1 FY26)
  • Employee benefits expense: ₹137.13 (Q1 FY27) vs ₹117.52 (Q1 FY26)
  • Finance costs: ₹5.35 (Q1 FY27) vs ₹2.42 (Q1 FY26)
  • Depreciation: ₹20.74 (Q1 FY27) vs ₹16.50 (Q1 FY26)
  • Other expenses: ₹107.45 (Q1 FY27) vs ₹115.71 (Q1 FY26)
  • Total Expenses: ₹414.20 (Q1 FY27) vs ₹390.21 (Q1 FY26)

Profitability Metrics

  • Profit Before Tax: ₹101.97 lakh (Q1 FY27) vs ₹89.55 lakh (Q1 FY26)
  • Tax Expense: ₹25.66 lakh (Q1 FY27) vs ₹22.55 lakh (Q1 FY26)
  • Net Profit: ₹76.31 lakh (Q1 FY27) vs ₹97.05 lakh (Q1 FY26) - decrease of 21.4% YoY
  • Earnings Per Share (Basic): ₹2.04 (Q1 FY27) vs ₹2.67 (Q1 FY26)
  • Earnings Per Share (Diluted): ₹1.96 (Q1 FY27) vs ₹2.61 (Q1 FY26)

Share Capital and Reserves

  • Paid-up Equity Share Capital: ₹374.97 lakh (face value ₹10 per share)
  • Reserves: Not specified for current quarter

Shareholding Pattern (As of June 30, 2026)

  • Public Shareholding: 2,383,172 shares (63.56%)
  • Promoter & Promoter Group: 1,366,528 shares (36.44%)
  • Pledged/Encumbered: 128,965 shares (3.44% of total capital)
  • Non-Encumbered: 1,237,563 shares (33.00% of total capital)
  • Year-over-Year Change: Promoter holding decreased from 39.25% in Q1 FY26 to 36.44% in Q1 FY27

Investor Complaints

  • No pending, received, disposed, or unresolved complaints during the quarter

Segment Information

  • The company operates in a single segment: "Life Saving Devices"

Consolidated Financial Results

Quarterly Performance (₹ in Lakhs)

  • Revenue from Operations: ₹489.67 (Q1 FY27) vs ₹534.30 (Q1 FY26)
  • Other Income: ₹2.68 (Q1 FY27) vs ₹2.35 (Q1 FY26)
  • Total Revenue: ₹492.35 (Q1 FY27) vs ₹536.65 (Q1 FY26)
  • Net Profit: ₹75.59 (Q1 FY27) vs ₹66.47 (Q1 FY26)
  • EPS (Basic): ₹2.02 (Q1 FY27) vs ₹1.85 (Q1 FY26)
  • Subsidiary Shree Coratomic Limited contributed revenues of ₹0.17 lakh and comprehensive loss of ₹0.72 lakh

Auditor Review

  • The financial results were subject to limited review by Agrawal Patel and Sinha, Chartered Accountants
  • The review was conducted in accordance with Standard on Review Engagements (SRE) 2410 issued by ICAI
  • The auditors concluded that nothing came to their attention suggesting material misstatement

Dates and Approvals

  • Quarter End: June 30, 2026
  • Board Meeting Date: August 13, 2026
  • Results Submission Date: August 13, 2026